We are live on ! Find out more
PAHC icon

Phibro Animal Health

208 hedge funds and large institutions have $660M invested in Phibro Animal Health in 2026 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 76 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.01% more ownership

Funds ownership: 98.72%99.73% (+1%)

5% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 76

19% less funds holding

Funds holding: 257208 (-49)

41% less capital invested

Capital invested by funds: $1.12B → $660M (-$464M)

56% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 80

76% less call options, than puts

Call options by funds: $477K | Put options by funds: $1.96M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
208
Holders Change
-49
Holders Change %
-19.07%
% of All Funds
2.5%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
35
Increased
80
Reduced
76
Closed
80
Calls
$477K
Puts
$1.96M
Net Calls
-$1.48M
Net Calls Change
+$1.2M

PAHC Hedge Fund Activity: Q2 2026 in Review

208 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2026, worth a combined $660M — down 41% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of PAHC and 35 opened new positions — a net loss of 45 holders — while 76 trimmed existing stakes and 80 added.

The largest buyer was Fidelity Investments, adding an estimated $41.7M. The largest seller was Acadian Asset Management, cutting an estimated $16.5M.

  • 208 institutional investors held Phibro Animal Health (PAHC) as of Q2 2026, down from 257 in Q1 2026.
  • Funds reported $660M of Phibro Animal Health stock for Q2 2026, down 41% quarter-over-quarter.
  • 35 funds opened new Phibro Animal Health positions in Q2 2026 and 80 closed out, a net change of -45 holders.
  • The largest Phibro Animal Health buyer in Q2 2026 was Fidelity Investments, an estimated $41.7M added.
  • The largest Phibro Animal Health seller in Q2 2026 was Acadian Asset Management, an estimated $16.5M sold.

Based on aggregated 13F filings for Q2 2026.